About GLP-1 (7-37)
Binds GLP-1 receptors in the pancreas, gut, and brain. Stimulates glucose-dependent insulin secretion and suppresses glucagon. Central GLP-1 receptor activation reduces food intake via hypothalamic pathways.
The active endogenous form of glucagon-like peptide-1, an incretin hormone released from intestinal L-cells after eating. The mechanistic basis for the GLP-1 receptor agonist drug class (semaglutide, liraglutide). Studied for glucose regulation and appetite suppression.
Research Areas
Regulatory & Evidence
Risk Profile
Generally considered lower risk in research contexts. Risk profile varies by individual — review contraindications before use.
Regulatory Status
- Availability Status
- Research Only
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Where to Find GLP-1 (7-37)
9 providersTelehealth Platforms
1 providerClinics
8 providersBluePath Longevity
United StatesView →Hormone Clinic Utah
United StatesView →Incite Health and Wellness
United StatesView →Longevity Clinic
United StatesView →Montana Mens Health
United StatesView →Peptides
United StatesView →Regain Functional Medicine and Aesthetics
United StatesView →The Hormone Hub
United StatesView →